Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications

Alzheimer-type dementia (ATD) treatments face limitations in crossing the blood–brain barrier and systemic adverse effects. Intranasal administration offers a direct route to the brain via the nasal cavity’s olfactory and trigeminal pathways. However, nasal physiology can hinder drug absorption and...

Descripción completa

Detalles Bibliográficos
Autores principales: Taléns-Visconti, Raquel, de Julián-Ortiz, Jesus Vicente, Vila-Busó, Ofelia, Diez-Sales, Octavio, Nácher, Amparo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223127/
https://www.ncbi.nlm.nih.gov/pubmed/37242641
http://dx.doi.org/10.3390/pharmaceutics15051399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223127/
https://www.ncbi.nlm.nih.gov/pubmed/37242641
http://dx.doi.org/10.3390/pharmaceutics15051399

Ejemplares similares